Das «MS State of the Art-Symposium» wurde am 23. Januar 2021 zum ersten Mal virtuell durchgeführt. Das Thema: «MS und Infektionskrankheiten». Dieses jährliche Symposium ist der bedeutendste MS-Fachkongress schweizweit. Es richtet sich an Neurologen, Ärzte, Forschende und paramedizinische Berufspersonen.
MS State of the Art Symposium 2021: Interview Christoph Lotter
C. Lotter zum «MS State of the Art Symposium», dem Stellenwert der Forschung und den Aufgaben der Schweiz. MS-Gesellschaft | Christoph Lotter, Co-Direktor...
C. Lotter zum «MS State of the Art Symposium», dem Stellenwert der Forschung und den Aufgaben der Schweiz. MS-Gesellschaft | Christoph Lotter, Co-Direktor Schweiz. MS-Gesellschaft
MS State of the Art Symposium 2021: Interview Milo Puhan
M. Puhan, Referent am MS State of the Art 2021, über seine Motivation und Forschungstätigkeit | Milo Puhan, University of Zurich, Epidemiology, Biostatistics...
M. Puhan, Referent am MS State of the Art 2021, über seine Motivation und Forschungstätigkeit | Milo Puhan, University of Zurich, Epidemiology, Biostatistics and Prevention Institute
Virtual MS State of the Art Symposium 2021 – Christoph Lotter
Christoph Lotter underlines the importance of research and thanks all participants and researchers for their fight against MS | Christoph Lotter, Co-Director...
Christoph Lotter underlines the importance of research and thanks all participants and researchers for their fight against MS | Christoph Lotter, Co-Director Swiss MS Society
Virtual MS State of the Art Symposium 2021 – Milo Puhan and Jan Fehr
The Corona Pandemic and MS - First Line Clinical, Epidemiological and Health Policy Insights | Jan Fehr, University Hospital Zurich, Department of Infectious...
The Corona Pandemic and MS - First Line Clinical, Epidemiological and Health Policy Insights | Jan Fehr, University Hospital Zurich, Department of Infectious Diseases and Hospital Epidemiology & Milo Puhan, University of Zurich, Epidemiology, Biostatistics and Prevention Institute | chaired by Adam Czaplinski, Bellevue Medical Group, Neurology FMH
Virtual MS State of the Art Symposium 2021 – Poster Blitz
Poster Blitz – MS Society Research Projects at a Glance | Introduction by Britta Engelhardt, University of Bern, Theodor Kocher Institute. The Swiss MS Society...
Poster Blitz – MS Society Research Projects at a Glance | Introduction by Britta Engelhardt, University of Bern, Theodor Kocher Institute. The Swiss MS Society supports research projects in the field of Multiple Sclerosis with considerable financial contributions. The «Poster Blitz» gives a brief overview of a selection of current research projects.
Virtual MS State of the Art Symposium 2021 – Robert Hoepner
Swiss Covid-19 Data in the European LEOSS Registry | Robert Hoepner, University Hospital Bern, Department of Neurology | chaired by Caroline Pot, Lausanne...
Swiss Covid-19 Data in the European LEOSS Registry | Robert Hoepner, University Hospital Bern, Department of Neurology | chaired by Caroline Pot, Lausanne University Hospital, Neurology Clinic
Virtual MS State of the Art Symposium 2021 – Céline Louapre
The French COVISEP Registry | Céline Louapre, Pitié Salpêtrière Hospital, Paris (FR), Department of Neurology & Sorbonne Université, Paris (FR), Institut du...
The French COVISEP Registry | Céline Louapre, Pitié Salpêtrière Hospital, Paris (FR), Department of Neurology & Sorbonne Université, Paris (FR), Institut du Cerveau | chaired by Caroline Pot, Lausanne University Hospital, Neurology Clinic
Virtual MS State of the Art Symposium 2021 – Matthias Mehling
MS and Vaccinations | Matthias Mehling, University Hospital Basel, Neurology Clinic and Policlinic | Research Center for Clinical Neuroimmunology and...
MS and Vaccinations | Matthias Mehling, University Hospital Basel, Neurology Clinic and Policlinic | Research Center for Clinical Neuroimmunology and Neuroscience | chaired by Gabrielle Di Virgilio, Centre Hospitalier de Rennaz, Neurology Unit
Virtual MS State of the Art Symposium 2021 – Renaud Du Pasquier
Risk of PML in Multiple Sclerosis Therapies | Renaud Du Pasquier, Lausanne University Hospital (CHUV), Service of Neurology | chaired by Ilijas Jelcic,...
Risk of PML in Multiple Sclerosis Therapies | Renaud Du Pasquier, Lausanne University Hospital (CHUV), Service of Neurology | chaired by Ilijas Jelcic, University Hospital Zurich, Neurology Clinic
Virtual MS State of the Art Symposium 2021 – Andrew Chan
Treatment Landscape of MS and NMOSD 2021| Andrew Chan, University Hospital Bern, Department of Neurology, Medical Division Neuro | chaired by Stefanie Müller,...
Treatment Landscape of MS and NMOSD 2021| Andrew Chan, University Hospital Bern, Department of Neurology, Medical Division Neuro | chaired by Stefanie Müller, Cantonal Hospital of St. Gallen, Neurology Clinic
Virtual MS State of the Art Symposium 2021 – Anke Salmen
Treatment Landscape of MS and NMOSD 2021 | Anke Salmen, University Hospital Bern, Department of Neurology | chaired by Stefanie Müller, Cantonal Hospital of St....
Treatment Landscape of MS and NMOSD 2021 | Anke Salmen, University Hospital Bern, Department of Neurology | chaired by Stefanie Müller, Cantonal Hospital of St. Gallen, Neurology Clinic